The Canadian Gastrointestinal society is committed to improving the lives of people with gastrointestinal and liver conditions, supporting research, advocating for appropriate patient access to health care, and promoting gastrointestinal and liver health, and their creating awareness about the benefits of medical cannabis.

The list of conditions that cannabis is purported to treat or cure is very long, and continues to grow, but the research is still lacking in many areas. This is largely due to cannabis being both stigmatized and illegal in most parts of the world for the past century, so research might increase as legalization becomes more commonplace. It is also difficult for researchers to conduct double-blind studies for most cannabis products because subjects might be able to determine whether they are on the active therapy or placebo.

However, current research indicates that some conditions may be clinically improved by cannabis use. These include inflammatory bowel disease,3 multiple sclerosis,4 neuropathic pain,5 nausea and vomiting caused by cancer or chemotherapy,6 pediatric seizure disorders,7 and a wide variety of other illnesses. Here, we will focus on gastrointestinal symptoms and conditions that might be ameliorated by cannabis. (source)

Click here to read more and learn more about medical cannabis and how it applies to IBD and other GI illnesses.